Trichloroethylene and Parkinson's Disease
三氯乙烯与帕金森病
基本信息
- 批准号:8738097
- 负责人:
- 金额:$ 15.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The goal of this work is to investigate occupational causes of Parkinson's disease (PD). The long-term neurological toxicity of occupational solvent exposure is poorly understood. Although acute Parkinsonism may rarely result from accidental high dose solvent exposures, these cases are clinically and pathologically distinct from PD. In contrast, epidemiologic associations of occupational exposures with typical PD are inconsistent. In 2008 Gash et al reported a cluster of 3 PD patients who had been exposed to the solvent trichloroethylene (TCE) in a manufacturing plant. Preliminary work in our population-based analytic study (the TWINS study) found a significant 6-fold increased risk of PD associated with occupational TCE exposure. The chlorinated solvents tetrachloroethylene (PERC, perchloroethylene) and carbon tetrachloride (CCl4) were also associated. In addition, a recent TCE model in rodents strikingly recapitulates many of the features of PD, further supporting the biological relevance of these observations. Two major deficiencies limit current understanding of the role of TCE, PERC and CCl4 in PD. First, few prior studies assessed exposure to specific agents, instead considering solvent exposure as a single categorical variable. Because solvents encompass a huge range of disparate compounds, association with any particular agent is likely to be obscured using this approach. A second deficiency in our knowledge is the lack of concomitant investigation of genetic and environmental factors that may affect solvent-related toxicity. This study will focus on the relationship between the industrial solvents TCE, PERC and CCl4 and PD risk, and will simultaneously consider interactions with genetic and environmental factors. We will leverage existing data derived over 15 years of research in 1,250 subjects from two well-characterized PD case-control study populations that share uniform, standardized, highly detailed occupational-task-specific interview methods. We will apply unbiased exposure estimation methods in order to quantify lifetime exposures to TCE, PERC, and CCl4, and test associations with PD. Using a larger independent cohort (SEARCH); we will test our preliminary findings in the TWINS study. This work is essential in order to establish a causal association. In addition, using existing DNA samples from both TWINS and SEARCH, we will test for interaction between these solvents and 1) variants in genes encoding enzymes involved in their metabolism, and 2) PD-associated genes. We will also test for interaction of solvents and environmental risk factors. The health implications of this work are immense. Solvents are ubiquitous in industry, and even a modest increased risk could have an enormous impact on the frequency of PD in workers. This work is essential to advance our knowledge of the risk posed by solvents, and will provide a rational foundation for protection of the workforce from this incurable debilitating disease.
描述(由申请人提供):这项工作的目标是调查帕金森病(PD)的职业原因。对职业性溶剂接触的长期神经毒性了解甚少。虽然急性帕金森症可能很少由意外高剂量溶剂暴露引起,但这些病例在临床和病理学上与PD不同。相反,职业暴露与典型PD的流行病学关联是不一致的。2008年,Gash等人报告了一组3名在制造厂暴露于溶剂三氯乙烯(TCE)的PD患者。我们基于人群的分析研究(TCE研究)的初步工作发现,与职业TCE暴露相关的PD风险显著增加6倍。氯化溶剂四氯乙烯(PERC,perchloroethylene)和四氯化碳(CCl 4)也有关联。此外,最近在啮齿动物中的TCE模型惊人地概括了PD的许多特征,进一步支持了这些观察结果的生物学相关性。 两个主要缺陷限制了目前对TCE、PERC和CCl 4在PD中的作用的理解。首先,很少有先前的研究评估暴露于特定的代理,而不是考虑溶剂暴露作为一个单一的分类变量。由于溶剂包含大量不同的化合物,因此使用这种方法可能会混淆与任何特定试剂的关联。我们知识的第二个不足是缺乏对可能影响溶剂相关毒性的遗传和环境因素的相应调查。 本研究将重点关注工业溶剂TCE、PERC和CCl 4与PD风险之间的关系,同时考虑与遗传和环境因素的相互作用。我们将利用来自1,250名受试者的15年研究的现有数据,这些受试者来自两个特征良好的PD病例对照研究人群,这些研究人群共享统一的,标准化的,高度详细的职业任务特异性访谈方法。我们将应用无偏的暴露估计方法来量化TCE、PERC和CCl 4的终生暴露,并测试与PD的关联。使用一个更大的独立队列(队列);我们将在Tandem研究中测试我们的初步发现。这项工作对于建立因果关系至关重要。此外,我们将使用来自TMF和TMF的现有DNA样本,检测这些溶剂与1)参与其代谢的酶编码基因变体和2)PD相关基因之间的相互作用。我们还将测试溶剂和环境风险因素的相互作用。 这项工作对健康的影响是巨大的。溶剂在工业中无处不在,即使是适度增加的风险也可能对工人的PD频率产生巨大影响。这项工作对于提高我们对溶剂风险的认识至关重要,并将为保护员工免受这种无法治愈的衰弱性疾病的侵害提供合理的基础。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samuel M. Goldman其他文献
Exposure to disulfiram and incidence of parkinsonism
- DOI:
10.1186/s12995-025-00454-9 - 发表时间:
2025-03-12 - 期刊:
- 影响因子:2.700
- 作者:
Angelo d’Errico;Elena Strippoli;Samuel M. Goldman;Paul D. Blanc - 通讯作者:
Paul D. Blanc
Heartbeat signature for predicting motor and non-motor involvement among nonparkinsonian LRRK2 G2019S mutation carriers
- DOI:
10.1007/s10286-024-01104-6 - 发表时间:
2025-02-19 - 期刊:
- 影响因子:3.400
- 作者:
Claudia Carricarte Naranjo;Connie Marras;Naomi P. Visanji;David J. Cornforth;Lazaro Sanchez‑Rodriguez;Birgitt Schüle;Samuel M. Goldman;Mario Estévez;Phyllis K. Stein;Herbert F. Jelinek;Anthony E. Lang;Andrés Machado - 通讯作者:
Andrés Machado
Samuel M. Goldman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samuel M. Goldman', 18)}}的其他基金
Parkinson's Disease and Exposure to Chlorinated Solvents at Marine Base Camp Lejeune
勒琼海军陆战队大本营的帕金森病和接触氯化溶剂
- 批准号:
9885842 - 财政年份:2020
- 资助金额:
$ 15.61万 - 项目类别:
相似国自然基金
99mTc-Annexin V显像早期诊断Parkinson's病的可行性研究
- 批准号:30400516
- 批准年份:2004
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
黑质-纹状体系统的神经胶质细胞反应在多巴胺神经元变性和Parkinson病发生中的作用
- 批准号:30371572
- 批准年份:2003
- 资助金额:20.0 万元
- 项目类别:面上项目
NR4A2基因多态性及其与Parkinson病的关系研究
- 批准号:30370509
- 批准年份:2003
- 资助金额:21.0 万元
- 项目类别:面上项目
相似海外基金
Human Dopamine Grafts in Alpha-Synuclein Models of Parkinson Disease
帕金森病α-突触核蛋白模型中的人多巴胺移植物
- 批准号:
10736403 - 财政年份:2023
- 资助金额:
$ 15.61万 - 项目类别:
Effects of deep brain stimulation (DBS) on laryngeal function and associated behaviors in Parkinson Disease
深部脑刺激(DBS)对帕金森病喉功能和相关行为的影响
- 批准号:
10735930 - 财政年份:2023
- 资助金额:
$ 15.61万 - 项目类别:
Determination of the clinical relevance of Parkinson disease-associated intronic enhancer of the alpha-synuclein gene, in a novel mouse deletion model
在新型小鼠缺失模型中确定帕金森病相关的α-突触核蛋白基因内含子增强子的临床相关性
- 批准号:
10665271 - 财政年份:2023
- 资助金额:
$ 15.61万 - 项目类别:
Leveraging a Natural Experiment to Determine the Effects of Integrated Palliative Care on Health Service Outcomes and Disparities in Parkinson Disease and Lewy Body Dementia
利用自然实验确定综合姑息治疗对帕金森病和路易体痴呆的卫生服务结果和差异的影响
- 批准号:
10701322 - 财政年份:2023
- 资助金额:
$ 15.61万 - 项目类别:
An Integrated Biomarker Approach to Personalized, Adaptive Deep Brain Stimulation in Parkinson Disease
帕金森病个性化、适应性深部脑刺激的综合生物标志物方法
- 批准号:
10571952 - 财政年份:2023
- 资助金额:
$ 15.61万 - 项目类别:
Parkinson Disease Neural Circuitry and Gastrointestinal Pathobiology
帕金森病神经回路和胃肠道病理学
- 批准号:
10740119 - 财政年份:2023
- 资助金额:
$ 15.61万 - 项目类别:
Cerebellar cholinergic connections as a biomarker of dementia and gait impairment in Parkinson disease
小脑胆碱能连接作为帕金森病痴呆和步态障碍的生物标志物
- 批准号:
10351813 - 财政年份:2022
- 资助金额:
$ 15.61万 - 项目类别:
Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and Genetics
帕金森病的种族差异 - 临床表型、治疗和遗传学
- 批准号:
10346329 - 财政年份:2022
- 资助金额:
$ 15.61万 - 项目类别:
Characterization of Alpha-Synuclein Aggregation Using Parkinson Disease Patient-Derived Midbrain Organoids
使用帕金森病患者来源的中脑类器官表征 α-突触核蛋白聚集
- 批准号:
474479 - 财政年份:2022
- 资助金额:
$ 15.61万 - 项目类别:
Studentship Programs
Musical rhythm synchronization as a mechanism to optimize gait in the real-world in persons with Parkinson disease
音乐节奏同步作为优化帕金森病患者现实世界步态的机制
- 批准号:
10534030 - 财政年份:2022
- 资助金额:
$ 15.61万 - 项目类别: